According to the USDA mastitis accounts for $400-$500 million, or $23 per cow, in lost production and revenue for dairy farmers nationwide. Further, mastitis can shorten the life expectancy of the cow and has negative effects on milk production after the cow goes through treatment. There is also evidence of a link between mastitis and biofilm formation on the surfaces of milking and processing systems. These biofilms can lead to further losses in quality premiums. This loss of revenue prevents the dairy farmer from putting capital back into operations.
One proven solution to reduce mastitis.
Implementation of a Mastitis Control Plan with special emphasis on mastitis treatment and routine pen/string sampling. Through general management and organization of the on-farm duties like bedding management and milking parlor procedures, a farm can make significant strides in controlling the spread of mastitis-causing bacteria like S. aureus and S. uberis. Animal management duties that emphasize an effective pre and post-dip process will also add value by stopping the spread of bacteria. How does the herd manager detect mastitis in the sub-clinical phase?
When the infected quarter is red, inflamed, and painful to the touch the mastitis is already in a clinical phase. This means immediate quarantine from the herd and a course of antibiotics. One approach to detecting mastitis before it reaches the clinical phase is weekly to bi-weekly pen/string sampling.
By finding mastitis when it is at sub-clinical levels, the production losses and cost of medications are lower. This translates to the cow being in the hospital group for a shorter duration, and back in the parlor creating revenue sooner. A routine pen sampling schedule reduces the operating costs of testing every cow when somatic cell counts in the bulk tank begin to rise. Early identification and management will lead to overall higher revenue and profits which dairy farmers desperately need in today’s market.